Iseganan: IB 367, Protegrin IB 367

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.1, 2002-01, pp. : 52-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IB-367: potential prophylactic against oral mucositis?

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 1, 2011-01 ,pp. : 35-41

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Platelet Glycoprotein Ib and Its Antithrombotic Potential

Current Pharmaceutical Design, Vol. 13, Iss. 26, 2007-09 ,pp. : 2684-2697

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

Leu 10 of -conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells

By Broxton N. Miranda L. Gehrmann J. Down J. Alewood P. Livett B.

European Journal of Pharmacology, Vol. 390, Iss. 3, 2000-03 ,pp. : 229-236

Elsevier

Access to resources Recommend Favorite